TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Forest Labs' Reward to Risk Ratio Hits the Spot Aaron Connell submits:I have always been a fan of a free lunch. Why pay when you can eat for free? The same thinking can be applied to equity markets. The best stocks are the ones that provide the free food. In down markets you may find securities in companies that throw an occasional buffet your way! However, these types of spreads are very rare in our current markets. In many situations you are lucky to get a free sandwich or worse --- table scraps. So where does this leave us? Should we forget about these types of opportunities and relegate ourselves to chasing prices? As value investors we need to stay patient and begin prospecting for the next free dining experience. I myself have been looking at a particular sector and stock that could yield such an opportunity.Complete Story » seekingalpha.com |
Enzo Biochem Reports Third Quarter Operating Results (Business Wire) NEW YORK----Enzo Biochem, Inc. , a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, today reported financial results for the three and nine months ended April 30, 2010. us.rd.yahoo.com |
Nu Skin Keep Your Age a Mystery Contest - Video NU SKIN LAUNCHES GLOBAL CONTEST TO IDENTIFY NEW 'FRESH FACES' OF AGELOC feedproxy.google.com |
Shell / Cosan's Big Bet on Biofuels The Burrill Report submits: By Marie DaghlianA $12-billion joint venture between Shell (RDS.A) and Brazilian ethanol producer Cosan (CZZ) moved closer to reality as the two companies signed binding agreements on the a deal first proposed in February. If completed, the deal will create the third largest ethanol producer in the world with 4,500 retail stations and annual production of 440 million gallons. Complete Story » seekingalpha.com |
The Case for Less Cancer Screening In The Research Report, Jeremy Singer-Vine summarizes new medical research on prostate cancer; smoking bans; warts; weight loss; multiple sclerosis and famine. online.wsj.com |